1 – 50 of 61
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor : results from 13 European registries
(
- Contribution to journal › Article
- 2023
-
Mark
Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population : a register-based study from Sweden
(
- Contribution to journal › Article
-
Mark
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis : an observational nationwide study
(
- Contribution to journal › Article
-
Mark
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
(
- Contribution to journal › Article
-
Mark
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
(
- Contribution to journal › Article
-
Mark
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice : Results from the ARTIS programme
(
- Contribution to journal › Article
-
Mark
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis : A Scandinavian Cohort Study
(
- Contribution to journal › Article
-
Mark
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis : results from five Nordic biologics registries
(
- Contribution to journal › Article
- 2022
-
Mark
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden
(
- Contribution to journal › Article
-
Mark
Comment on : Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: Results from a national register-based cohort study. Reply
(
- Contribution to journal › Letter
-
Mark
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs : Results from four Nordic countries
(
- Contribution to journal › Article
-
Mark
Association Between Inflammatory Bowel Disease and Spondyloarthritis : Findings from a Nationwide Study in Sweden
(
- Contribution to journal › Article
-
Mark
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis : Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
(
- Contribution to journal › Article
-
Mark
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors : Data from the EuroSpA collaboration
(
- Contribution to journal › Article
- 2021
-
Mark
Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population : a nationwide register-based cohort study 2002–2017
(
- Contribution to journal › Article
-
Mark
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care : Does the choice of biological therapy matter?
(
- Contribution to journal › Article
-
Mark
Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis : Results from a national register-based cohort study
(
- Contribution to journal › Article
-
Mark
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine
(
- Contribution to journal › Article
-
Mark
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers
(
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population : A nationwide Swedish cohort study
(
- Contribution to journal › Article
-
Mark
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden : From infection severity to impact on care provision
(
- Contribution to journal › Article
-
Mark
Adaptation of the charlson comorbidity index for register-based research in sweden
(
- Contribution to journal › Article
-
Mark
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics : A Nordic population-based cohort study
(
- Contribution to journal › Article
-
Mark
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis
(
- Contribution to journal › Article
- 2020
-
Mark
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
(
- Contribution to journal › Article
-
Mark
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis : results from a nationwide study in Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Biological treatment of ankylosing spondylitis : A nationwide study of treatment trajectories on a patient level in clinical practice
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA : Results from the nationwide Swedish register
(
- Contribution to journal › Article
- 2018
-
Mark
Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis A nationwide population-based cohort study
(
- Contribution to journal › Article
-
Mark
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis : A population-based nationwide study
(
- Contribution to journal › Article
-
Mark
Uptake of rheumatology biosimilars in the absence of forced switching
(
- Contribution to journal › Article
-
Mark
Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population : A register-based study from Sweden
(
- Contribution to journal › Article
- 2017
-
Mark
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
(
- Contribution to journal › Article
-
Mark
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors : A collaborative study from the ARTIS and DANBIO registers
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.
(
- Contribution to journal › Article
- 2016
-
Mark
Childhood hospitalisation with infections and later development of ankylosing spondylitis : A national case-control study
(
- Contribution to journal › Article
-
Mark
Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers.
(
- Contribution to journal › Article
-
Mark
Mortality in ankylosing spondylitis: results from a nationwide population-based study.
(
- Contribution to journal › Article
-
Mark
Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
2016) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
- 2015
-
Mark
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
(
- Contribution to journal › Article
-
Mark
Does disease activity at start of biologic therapy influence work-loss in RA patients?
2015) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.
(
- Contribution to journal › Article
- 2014
-
Mark
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register
(
- Contribution to journal › Article
-
Mark
Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects.
(
- Contribution to journal › Article
-
Mark
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
(
- Contribution to journal › Article
- 2013
-
Mark
Increased Risk of Arthropathies and Joint Replacement Surgery in Patients With Genetic Hemochromatosis: A Study of 3,531 Patients and Their 11,794 First-Degree Relatives
(
- Contribution to journal › Article
-
Mark
Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.
(
- Contribution to journal › Article
-
Mark
Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis
(
- Contribution to journal › Article
- 2012
-
Mark
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
(
- Contribution to journal › Article